World's Best Scientists 2026 revealed!
E. Jenny Heathcote

E. Jenny Heathcote

D-Index & Metrics

Medicine

D-Index
75
Citations
31320
World Ranking
18984
National Ranking
801

E. Jenny Heathcote publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where E. Jenny Heathcote sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 159 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

E. Jenny Heathcote D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where E. Jenny Heathcote sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

E. Jenny Heathcote is affiliated with the University of Toronto in Canada and has a research focus within the field of Medicine, with a particular concentration in Surgery. Their work spans several subfields including Oncology, Otorhinolaryngology, Molecular Biology, and Rheumatology.

The scientist has contributed extensively to research on head and neck cancers, especially adenoid cystic carcinoma. Key topics in their research portfolio include:

  • Salivary Gland Tumors Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Head and Neck Anomalies
  • Colorectal and Anal Carcinomas
  • Chromatin Remodeling and Cancer
  • Pancreatic and Hepatic Oncology Research
  • Bone Tumor Diagnosis and Treatments

Their recent publications illustrate an ongoing engagement with molecular and clinical aspects of cancer research. Notable papers include:

  • Clinical and genomic characterisation of adenoid cystic carcinoma of the head and neck, lung, and breast, 2023, Journal of Clinical Oncology
  • Gene expression patterns in adenoid cystic carcinoma with and without diffuse NOTCH1 intracellular domain (NICD1) immunohistochemistry staining, 2023, Oral Oncology
  • 904P Analysis of TP63 immunohistochemistry scores (IHC) by primary site and between primary and metastatic tumours in adenoid cystic carcinoma (ACC), 2024, Annals of Oncology
  • KDM6A, ARID1A and SETD2 loss-of-function mutations as prognostic biomarkers and their association with sites of metastatic progression in locally-advanced, recurrent or metastatic adenoid cystic carcinoma, 2025, Oral Oncology
  • Association of quality of life with mortality in patients with adenoid cystic carcinoma using an internationally-validated QoL questionnaire (EQ-5D-5L), 2025, Oral Oncology

Publication venues where this scientist has frequently contributed include:

  • Oral Oncology
  • Journal of Clinical Oncology
  • Annals of Oncology
  • Clinical Cancer Research

Frequent co-authors collaborating with E. Jenny Heathcote encompass Robert Metcalf, Samuel Rack, Guy Betts, Kevin J. Harrington, and Karan Patel. Such collaborations highlight an active involvement in multidisciplinary research teams.

Best Publications

  • Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

    Patrick Marcellin;Edward J Gane;Maria Buti;Nezam H Afdhal

  • Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B

    Patrick Marcellin;E Jenny Heathcote;Maria Buti;Ed Gane

  • Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.

    E. J. Heathcote;M. L. Shiffman;W. G. E. Cooksley;G. M. Dusheiko

  • Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

    Anna S.F. Lok;Ching Lung Lai;Nancy Leung;Guang Bi Yao

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting–Tsung Chang

  • Telbivudine versus lamivudine in patients with chronic hepatitis B.

    Ching-Lung Lai;Edward Gane;Yun-Fan Liaw;Chao-Wei Hsu

  • Management of hepatitis B: 2000--summary of a workshop.

    Anna S. Lok;E.Jenny Heathcote;Jay H. Hoofnagle

  • Histological outcome during long-term lamivudine therapy.

    Jules L. Dienstag;Robert D. Goldin;E.Jenny Heathcote;H.W.L. Hann

  • 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B

    Yun–Fan Liaw;Edward Gane;Nancy Leung;Stefan Zeuzem

  • Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

    Marion G. Peters;H. W. Hann;Paul Martin;E. Jenny Heathcote

  • Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis

    Bart J Veldt;E Jenny Heathcote;Heiner Wedemeyer;Juerg Reichen

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

    Jean-Pierre Villeneuve;Lynn D. Condreay;Bernard Willems;Gilles Pomier-Layrargues

  • Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

    RE Poupon;KD Lindor;K Cauch-Dudek;ER Dickson

  • Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

    Gideon M. Hirschfield;Xiangdong Liu;Chun Xu;Yue Lu

  • Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

    E. Jenny Heathcote;Patrick Marcellin;Maria Buti;Edward Gane

  • Management of primary biliary cirrhosis

    E. Jenny Heathcote

  • The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

    E. Jenny Heathcote;Karen Cauch-Dudek;Valery Walker;Robert J. Bailey

  • Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

    Xiangdong Liu;Pietro Invernizzi;Yue Lu;Roman Kosoy

Frequent Co-Authors

Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Antonio Craxì
Antonio Craxì University of Palermo
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Keith D. Lindor
Keith D. Lindor Arizona State University
Edward Gane
Edward Gane Auckland City Hospital
Eugene R. Schiff
Eugene R. Schiff University of Miami
Christopher I. Amos
Christopher I. Amos Baylor College of Medicine
Massimo Colombo
Massimo Colombo Humanitas University
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring alternatives or complementary careers to traditional medical degrees, several flexible and accessible options can be found online. A popular route is pursuing direct entry msn programs online, designed for non-nurses wanting to fast-track into advanced nursing roles. These programs often provide a path to high-demand healthcare positions in less time than traditional tracks.

Getting into nursing can also be more accessible through direct admit nursing programs that offer streamlined admissions processes. Some schools even eliminate testing barriers, with nursing schools that don't require teas or HESI exams, making entry easier for many students.

Those interested in administrative or technical roles in healthcare might consider medical billing and coding schools that accept financial aid. These programs offer flexible online learning and financial support, leading to fulfilling careers that support patient care from behind the scenes.

Best Scientists Citing E. Jenny Heathcote

Trending Scientists